Since the activity of the mammalian target of rapamycin (mTOR) is sensitive to serum and nutrient, this suggests that p21 might contribute to oncogenesis by playing a role in the adaptive response of cancer cells to the low-nutrient environment that typically characterizes the central region of solid tumors. The gene discussed is CDKN1A; the disease is cancer.